Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Celanese Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $5.2B | |
|---|---|---|
| Revenue (ttm) | 9.7B | |
| Net income (ttm) | -1.2B | |
| EPS (ttm) | -$10.7 | |
| Shares out | 109.7M | |
| P/E (forward) | 7.2x | |
| Dividend | $0.12 (0.25%) | |
| Volume | 699,949 | |
| Beta | 0.76 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $8.54B | $9.67B | $10.93B | $10.27B | $9.54B | +2.8% |
| Gross profit | $2.68B | $2.38B | $2.58B | $2.34B | $1.95B | -7.6% |
| Operating income | $1.95B | $1.38B | $1.67B | $-720.0M | $-786.0M | — |
| Net income | $1.89B | $1.89B | $1.94B | $-1.54B | $-1.17B | — |
| EPS (diluted) | $16.86 | $17.34 | $17.76 | $-14.11 | $-10.64 | — |
| EBITDA | $2.72B | $2.30B | $2.61B | $503.0M | $335.0M | -40.7% |
| R&D | $86.0M | $112.0M | $146.0M | $130.0M | $125.0M | +9.8% |
| SG&A | $633.0M | $824.0M | $1.08B | $1.03B | $899.0M | +9.2% |
Recent company headlines from major financial publishers.
Global industrial demand and automotive assembly rates rebound robustly, driving strong volume growth for Engineered Materials. Acetyl Chain pricing remains elevated as Western Hemisphere supply chain advantages persist. Rapid debt retirement reduces annual interest expense, accelerating EPS growth and unlocking multiple expansion toward historical peak levels.
Celanese executes on its core operational strategy: modest revenue growth, steady recovery in Engineered Materials margins via footprint actions, and resilient cash generation from the Acetyl Chain. Free cash flow is disciplined and deployed exclusively to debt reduction, steadily lowering financial leverage and driving intrinsic value convergence to $76.31.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 7.4% | $83.4 | $85.8 | $88.3 | $91.2 | $94.3 |
| 7.9% | $77.7 | $79.7 | $81.8 | $84.2 | $86.7 |
| 8.4% | $72.9 | $74.5 | $76.3 | $78.2 | $80.3 |
| 8.9% | $68.7 | $70.1 | $71.6 | $73.2 | $74.9 |
| 9.4% | $64.9 | $66.1 | $67.4 | $68.8 | $70.3 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
